Overall rank by patents
#26,333
Across all tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 9 technology areas, active 2015–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).
The verdict
Fondazione holds 10 US patents across 9 technology areas, rank #26,333 of 50,000 tracked assignees.
Fondazione Irccs Istituto Nazionale Dei Tumori has been granted 10 US utility patents between 2015 and 2024, placing Fondazione Irccs Istituto Nazionale Dei Tumori at rank #26,333 across all assignees tracked by PlainPatent. This portfolio spans 9 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.1 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a Foreign Corporation, Fondazione Irccs Istituto Nazionale Dei Tumori is one of the more focused assignees in the PatentsView dataset. By volume, Fondazione sits between Flyer Next, Llc (10 patents, rank #26,329) and Forest Concepts, Llc (10 patents, rank #26,337) - the closest US assignees by grant volume. The composite Innovation Score of 33.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 5 grants, compared with 5 in the 2015–2019 window, a +0% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Fondazione Irccs Istituto Nazionale Dei Tumori's 15.1 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 9 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Fondazione Irccs Istituto Nazionale Dei Tumori against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Flyer Next, LLC
10 patents
Flying Cloud Technologies, Inc.
10 patents
Foldax, Inc.
10 patents
Fondazione Bruno Kessler
10 patents
For Life Products, LLC
10 patents
Force10 Networks, Inc.
10 patents
Forcepoint Federal Holdings LLC
10 patents
Forest Concepts, LLC
10 patents
Fondazione IRCCS Istituto Nazionale Dei Tumori
10 patents
What this shows Fondazione holds 10 patents at rank #26,333, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Fondazione's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
33 Top 57% higher than 43% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 20.0% |
| 2018 | 1 | 10.0% |
| 2019 | 2 | 20.0% |
| 2020 | 1 | 10.0% |
| 2021 | 1 | 10.0% |
| 2023 | 1 | 10.0% |
| 2024 | 2 | 20.0% |
Top 9 of 9 technology areas
Overall rank by patents
#26,333
Across all tracked assignees
33.0 out of 100
How to use this portfolio
Fondazione's 10 grants land it in the top 57% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.